Ballard Spahr, Seven Attorneys Recognized by LMG Life Sciences

Ballard Spahr and seven of its Life Sciences industry team attorneys are recognized in the recently released 2024 edition of LMG Life Sciences, a directory of the leading law firms and lawyers serving the industry.

Ballard Spahr is specially recognized in the Patent Prosecution category, reflective of the firm’s extensive work securing patent protection for our clients’ life sciences innovations. Individual Ballard Spahr attorneys are also ranked for their life sciences-related work in Patent Prosecution, as well as General Patent Litigation, Hatch-Waxman Patent Litigation, Patent Strategy & Management, Licensing & Collaboration, Mergers & Acquisitions, and Antitrust.

The individual attorneys ranked are:

Caryn Borg-Breen, Ph.D.: General Patent Litigation, Hatch-Waxman Patent Litigation

Margaret Bolce Brivanlou, Ph.D.: Patent Strategy & Management

Brian D. Doerner: Licensing & Collaboration, Mergers & Acquisitions

Stephen J. Kastenberg: Antitrust

Scott D. Marty, Ph.D.: Patent Prosecution, Patent Strategy & Management

Barbara Lano Rummel: Mergers & Acquisitions

Kenneth H. Sonnenfeld, Ph.D.: General Patent Litigation, Patent Strategy & Management

LMG Life Sciences builds its directory using case evidence, peer feedback, and client feedback. For further information, please see its methodology page.

Ballard Spahr’s Life Sciences attorneys focus on industry-specific matters spanning the legal areas of business and transactions, finance, litigation, intellectual property, and real estate. Industry team members serve life sciences businesses throughout the corporate lifecycle, including innovation, commercialization, and product management.

For media inquiries, please contact Bill Shralow at 215.864.8195.